Tissue fibrosis evolving from impaired tissue remodeling after injury is characterized by myofibroblast accumulation. We propose that during the development of fibrosis myofibroblasts acquire an immune-privileged cell phenotype, allowing their uninterrupted accumulation. Using the murine model of bleomycin-induced lung fibrosis in mice, we show that myofibroblasts that accumulate in lungs with fibrosis, but not in normal lungs, kill Fas ؉ lymphocytes, resist Fas-induced apoptosis, and survive longer when grafted into allogeneic mice. In contrast, bleomycin-treated FasLigand (FasL)-deficient (gld) chimeric mice did not accumulate myofibroblasts or collagen in their lungs, and their FasL ؊ myofibroblasts did not survive after alloengraftment. This finding indicates that myofibroblasts possess Fas/FasL-pathway-dependent characteristics that allow them to escape from immune surveillance and resulting organ fibrosis.
Tissue fibrosis evolving from impaired tissue remodeling after injury is characterized by myofibroblast accumulation. We propose that during the development of fibrosis myofibroblasts acquire an immune-privileged cell phenotype, allowing their uninterrupted accumulation. Using the murine model of bleomycin-induced lung fibrosis in mice, we show that myofibroblasts that accumulate in lungs with fibrosis, but not in normal lungs, kill Fas ؉ lymphocytes, resist Fas-induced apoptosis, and survive longer when grafted into allogeneic mice. In contrast, bleomycin-treated FasLigand (FasL)-deficient (gld) chimeric mice did not accumulate myofibroblasts or collagen in their lungs, and their FasL ؊ myofibroblasts did not survive after alloengraftment. This finding indicates that myofibroblasts possess Fas/FasL-pathway-dependent characteristics that allow them to escape from immune surveillance and resulting organ fibrosis.
Fas/FasL ͉ immune privilege U nder normal conditions, myofibroblasts play an essential role in the resolution of inf lammation and scar formation; however, recovery from injury requires their subsequent disappearance from the injured site (1) . Myofibroblast eradication during normal lung repair depends on factors that maintain their survival (2) and on Fas Ligand (FasL)-induced apoptosis (3) primarily by immune T cells (4) , maintaining tissue homeostasis (5) .
The pathogenesis of pulmonary fibrosis is typically characterized by abnormalities of alveolar structure accompanied by myofibroblast accumulation and collagen deposition in the extracellular matrix, with resulting lung scarring and inhibition of gas exchange (2) . Intratracheal administration of bleomycin has been widely used as a model to study the mechanisms underlying lung injury, inflammation, and repair (6, 7) .
In contrast to normal regenerating tissue, resistance to Fasinduced apoptosis was detected in lung myofibroblasts of humans with idiopatic pulmonary fibrosis (IPF) (3) , implying that fibrotic lung myofibroblasts may evade immune cell-induced apoptosis, thus allowing for their uninterrupted accumulation.
Evasion of immune surveillance and the ability to undergo uninterrupted proliferation are characteristics of cancer cells, which possess features of immune-privileged tissues (8, 9) . Their features also include the ability to resist Fas-induced apoptosis (10) after binding of FasL expressed by immune cells, and the expression of a functional FasL, which enables the counterattack of neighboring Fas-expressing immune cells, thus allowing for abnormal cell accumulation.
The functional role of immune cells in lung injury (and repair) and fibrosis is multifaceted (1, (11) (12) (13) . To shed more light on one aspect of this issue, we evaluated the specific interaction between immune T cells and lung myofibroblasts in vitro and in vivo. Our data suggest that myofibroblasts employ a mechanism involving immune-privileged cell phenotypes. This mechanism enables them to avoid clearance by cells maintaining tissue homeostasis, leading to a diversion from normal tissue remodeling and the development of lung fibrosis.
Results

Fibrotic Rather Than Normal Lung Myofibroblasts Overexpress Fas but
Are Resistant to Fas-and Immune Cell-Induced Apoptosis. To assess the sensitivity of lung myofibroblasts to Fas-induced apoptosis, we initially determined their Fas level of expression. When compared with normal myofibroblasts isolated from salinetreated lungs, myofibroblasts isolated from fibrotic lungs of bleomycin-treated C57BL/6 mice overexpress Fas molecules (Fig. 1A) . We further tested Fas-induced myofibroblast apoptosis by assessing its response to Jo2 Fas-agonist mAb. Flowcytometry analysis revealed that, in comparison with normal lung myofibroblasts, myofibroblasts isolated from bleomycintreated lungs lost their sensitivity to Fas-induced apoptosis (3% apoptosis with IgG isotype-matched control vs. 3.4% with Jo2 mAb) (Fig. 1B Right) . In contrast, the extent of Fas-induced apoptosis from normal saline-treated lung myofibroblasts increased (0% apoptosis with IgG control vs. 22% with Jo2 mAb) (Fig. 1B Left) .
The resistance to apoptosis exerted by fibrotic lung myofibroblasts was confirmed by parallel experiments where myofibroblasts were cocultured with 5 ϫ 10 6 Jurkat T lymphocytes at a ratio of 1:5. Viable myofibroblasts were counted by using trypan blue staining and analyzed by confocal microscopy. Jurkat T cells induced the death of myofibroblasts from saline-, but not bleomycin-treated, mouse lungs (Fig. 1C) .
Myofibroblasts from Fibrotic Lungs Kill Lymphocytes by FasL/Fas
Interaction. We have previously shown the expression of FasL on myofibroblasts in fibrotic lungs of humans with IPF and mice with bleomycin-induced fibrosis (14) . Constitutive expression of FasL, observed in immune-privileged tumor cells, has been shown to induce apoptosis of infiltrating lymphocytes (15, 16) .
We found that myofibroblasts isolated from fibrotic lungs of bleomycin-treated WT mice express a functional FasL (14) capable of inducing Fas/FasL-dependent apoptosis in unsorted naïve thymocytes ( Fig. 2A) , activated primary T cells (Fig. 2B) , and in the Jurkat T cell line (Fig. 2C) .
Myofibroblasts (5 ϫ 10 5 ) were cocultured at a 1:2 ratio for 24 h, with 1 ϫ 10 6 Fas ϩ or Fas Ϫ target lymphocytes extracted from WT or Fas-defective (lpr) mice, respectively. No change in apoptosis levels was detected between Fas Ϫ thymocytes in the control (17%) and coculture (14%) experiment (Fig. 2 A Right) , whereas apoptosis in Fas ϩ thymocytes increased from 9% in controls to 34% when cocultured with myofibroblasts ( Fig. 2 (14) .
After bleomycin lung instillation, myofibroblast accumulation was markedly decreased in the lungs of chimeric gld mice, compared with their WT control counterparts, although CD3 ϩ lymphocyte infiltrates were detected in both mice (Fig. 3A) .
Consistent with these results, there was increased collagen deposition in the lungs of bleomycin-treated control WT mice (FasL ϩ ) but not in lungs of bleomycin-treated gld (FasL Ϫ ) chimeric mice (Fig. 3B) . However, lung inflammation, as assessed by bronchoalveolar lavage (BAL) fluid cellularity, was similar in the lungs of both WT and gld chimeric mice (Fig. 3C) .
Using confocal microscopy, we determined in lung sections in vivo whether bleomycin-treated lung ␣SMA ϩ cells induce FasLdependent apoptosis of adjacent Fas ϩ lymphocytes (Fig. 3D ). To this end, lung sections from bleomycin-treated chimeric gld or control mice were triple stained with anti-CD3, anti-caspase-3, and anti-␣SMA Abs. CD3
ϩ cells adjacent to ␣SMA ϩ cells from control mice stained positive for caspase-3 activity ( 18). Therefore, in an allogeneic inflammatory environment, we tested the in vivo characteristics of fibrotic lung myofibroblasts evading immune surveillance and their resulting accumulation.
The air pouch is a well documented model for characterizing immune inflammatory responses (19, 20) . We further verified, by using air pouches, whether myofibroblasts isolated from bleomycin-treated lungs are able to avoid immune surveillance after alloengraftment. Myofibroblasts from lungs of bleomycin-or saline-treated C57BL/6 mice were stained with CFSE and further injected into the dorsal air pouches of allogeneic BALB/c and syngeneic C57BL/6 mice.
We initially confirmed an inf lammatory response to allogeneic transplantation of myofibroblasts from the lungs of either bleomycin-or saline-treated C57BL/6 mice. Differential analysis of inf lammatory cells in host air pouches revealed that the highest proportion of Ϸ2 ϫ 10 4 cells recovered from each air pouch were granulocytes (40 -50%), with smaller percentages of macrophages (30 -40%) and lymphocytes (10 -20%) (Fig. 4A) . No significant differences were observed in the number or composition of pouch cells recovered after allogeneic transplantation of myofibroblasts from normal saline-and fibrotic bleomycin-treated mouse lungs (data not shown). A concomitant increase in myofibroblast expression of MCP-3 mRNA, a chemokine known to recruit inf lammatory cells (21) , was found on days 1 and 7 after allogeneic transplantation from either fibrotic (bleomycin-treated) or normal (salinetreated) allogeneic mouse lungs (Fig. 4B) .
Myofibroblast survival was demonstrated on day 7 by detection of a green fluorescent signal using a fluorescent microscope (Fig. 4C) . In syngeneic mice, positive green fluorescence was detected in myofibroblasts after transplantation from both normal (saline: FasL ϩ ) and fibrotic (bleomycin: FasL ϩ ) lungs ( treated mice showed similar in vivo accumulation capacities in the air pouches of syngeneic C57BL/6 mice ( Fig. 4D ; C57BL/6: saline and bleomycin). In allogeneic BALB/c mice, only myofibroblasts from fibrotic lungs (bleomycin) displayed a positive green fluorescence signal ( Fig. 4D ; BALB/c) (P Ͻ 0.01), which further decreased by day 30 (data not shown). We then determined whether FasL plays a role in the accumulation after alloengraftment (BALB/c) of fibrotic bleomycintreated lung myofibroblasts and found that FasL ϩ myofibroblasts survive in both BALB/c and in the control C57BL/6 mice. However, FasL Ϫ myofibroblasts survive only in C57BL/6, but not in allogeneic BALB/c mice (Fig. 4 C Center and Right and E; FasL ϩ vs. FasL Ϫ in BALB/c Ϫ , compared with C57BL/6, mice).
Discussion
Apoptosis, generally induced by immune cells that are known to function as the so-called first line of defense after tissue injury (22) , was shown to mediate decreased myofibroblast accumulation during the repair from injury (23) . However, in many instances, tissue remodeling does not occur, and granulation tissue evolves into a hypertrophic scar containing myofibroblasts and an inappropriate production of extracellular matrix. This general process is a scheme for fibrosis formation, which applies to many organs after different types of injury (e.g., kidney, liver, heart, and lung). Our study was based on the initial finding that, in the experimental murine model of bleomycin-induced lung fibrosis, myofibroblasts from normal, but not from fibrotic lungs, are sensitive to the induction of apoptosis exerted by immune cells. We hypothesized that, in lung fibrosis, myofibroblasts adopt strategies to avoid apoptosis and consequent clearance by the immune system. Among the mechanisms that could be employed by fibrotic lung myofibroblast to avoid immune cell-induced apoptosis (24-27), we tested the involvement of the FasL pathway (10) .
We initially show that Jo2 anti-Fas mAb induces the membranal expression of the phosphatidylserine apoptosis marker, as detected by Annexin V binding, in normal, but not in fibrotic, lung myofibroblasts. This finding may explain the defects in their recognition and removal by immune cells (28) (29) (30) , resulting in their accumulation in lungs.
Resistance to Fas-induced apoptosis represents at least, in part, a mechanism by which fibrotic lung myofibroblasts appear invisible to immune cells. Importantly, similar sensitivity to Fas-induced apoptosis was previously reported in myofibroblasts from normal human lungs, compared with those from lungs of humans with IPF (5, 31, 32) . These observations are also in accordance with a previous report showing loss of fibroblast resistance to apoptosis during normal repair after acute lung injury (33) .
The apparent contradiction between the findings that fibrotic lung myofibroblasts express relatively higher levels of Fas molecules, yet resist Fas-induced apoptosis, may be because of the up-regulation of the Fas apoptotic signal inhibitor, FLIP (34) , or the release of soluble FasL, or the lack of Fas transmembrane or death domains, or a combination of these possibilities (35) (36) (37) .
The ability of the cell to counterattack immune cells by its expression of FasL (17) is an additional and complementary characteristic that supports avoidance from immune surveillance.
We recently reported that fibrotic lung myofibroblasts overexpress FasL and function as effector cells capable of inducing Fas/FasL-dependent apoptosis in lung epithelial cells in vitro and in vivo (14) . In this study, we show their ability to induce in vitro apoptosis in a variety of T cells, with Fas/FasL dependency.
Concomitantly, chimeric FasL-deficient gld mice with FasLdeficient myofibroblasts exhibited no caspase-3 activity in adjacent CD3 ϩ cells, compared with WT (FasL ϩ ) mice, suggesting their inability to counterattack immune cells in vivo, as well as their dependence on FasL expression. Myofibroblasts' ability to resist lymphocyte-induced apoptosis, as well as to induce apoptosis in lymphocytes, may be the cause of myofibroblast accumulation, with resulting collagen deposition, in the lungs of bleomycin-treated mice.
These results support the notion that, just like cancer cells, fibrotic lung myofibroblasts accumulate because of their ability to evade immune surveillance.
Moreover, using the air pouch model, which is an established tool used to assess immune inflammatory responses (19, 20) in allogeneic BALB/c mice, we showed that fibrotic lung myofibroblasts undergo a delayed rejection that is dependent on their FasL expression, implying their acquired ability to evade allogeneic immune surveillance.
We propose that the differential survival of normal and fibrotic lung myofibroblasts in allogeneic mice has implications for myofibroblast accumulation in the inflammatory/fibrotic lung environment. Moreover, increased cell growth of FasLpositive myofibroblasts could indicate a growth advantage over other lung cells, not just a specific ability to counterattack T cells. Therefore, to address this question, we established the air pouch model in allogeneic mice. The lung environment is now excluded, thus relating fibrotic lung myofibroblast accumulation to evasion from immune surveillance rather than interaction with other cells of the lung.
The loss of caspase-3 activity in ␣SMA ϩ -adjacent CD3 ϩ cells, detected in FasL-deficient bleomycin-treated chimeric mice, supports a specific interaction between the FasL on myofibroblasts and immune cells in vivo. However, because gld chimeric mice exclude FasL deficiency only on hematopoietic cells, it remains possible that, after the loss of their FasL expression, other cell types contribute to impaired accumulation of myofibroblasts in the lungs of these mice. Other FasL ϩ effector cells of the nonhematopoietic cell lineage, such as epithelial cells, could have affected myofibroblast accumulation in chimeric gld mice, via regulation of the inflammatory response (38) by FasL (39) after injury. However, the similar inflammation that we detected in bleomycin-treated chimeric gld and WT mice does not support this possibility.
Additional mechanisms by which myofibroblast FasL expression is critical in their accumulation during lung fibrosis, besides their counterattack of immune cells, are possible. FasL in myofibroblasts may function as a proliferation signaling receptor, similar to T cells, where FasL was shown to positively regulate their proliferative capacity (40) . Myofibroblast may perform an autocrine FasL/Fas-induced proliferation. This possibility can be supported by the detection of increased Fas/FasL expression (14) , the previous report on myofibroblast Fas-induced proliferation (41) , and the possible autocrine Fas/FasL interaction.
In summary, our study identifies a previously unrecognized role for Fas/FasL signaling, which provides a mechanism for myofibroblast accumulation during lung fibrosis. Fibrotic lung myofibroblasts resist Fas-induced apoptosis and kill a variety of T cells. FasL contributes to prolonged myofibroblast survival after transplantation into allogeneic host mice, as well as to increased myofibroblast accumulation, with collagen deposition, in the lungs of bleomycin-treated mice. Moreover, cell-specific FasL deficiency reverses this phenotype, demonstrating its importance in myofibroblast acquisition of an immune privilege mechanism governing cell growth. Based on these findings, we propose that specific immune surveillance of lung myofibroblasts fails because of the emergence of their immune-privileged cell phenotype. The failure of this immune response appears to play a critical role in the evolution of lung fibrosis, and it may have similar consequences for fibrosis in other organs.
Materials and Methods
Reagents. mAbs and other reagents included 1 mg/ml propidium iodide (PI) stock solution (Calbiochem) in PBS; CFSE (Molecular Probes); rabbit antihuman/mouse active-caspase-3 mAb (R&D Systems); mouse anti-mouse ␣SMA mAb (Sigma-Aldrich); Annexin V-FITC, phycoerythrin-conjugated Fas, and Jo2 anti-Fas mAb with IgG; rabbit anti-mouse CD4 and CD62L mAbs, rat antimouse CD31, and F4/80 mAbs (Pharmingen); and FITC-conjugated F(ab)2 goat anti-rat IgG (H&L), Cy2-conjugated goat anti-hamster IgG (H&L), Cy3-conjugated donkey anti-rabbit IgG (H&L), and Cy5-conjugated goat antimouse IgG (H&L) (Jackson Immunoresearch Laboratories). Rat KM81 (IgG2b), anti-mouse pan CD44 mAbs (constant region-specific), and rat 2C11a (IgG1) anti-mouse CD3 mAb were generated from American Type Culture Collection hybridomas and further purified by protein S-Sepharose chromatography (42), Tri reagent (T9424; Sigma-Aldrich), a reverse transcription system (Promega, Madison, WI), and TaqDNA polymerase and ethidium bromide (Sigma-Aldrich).
Animals. The 11-to 12-week-old male C57BL/6 and BALB/c mice were purchased from Harlan-Sprague-Dawley. The 11-to 12-week-old Tg(ACTB-EGFP)10sb and 5-to 6-week-old lpr and gld C57BL/6-based mice were purchased from The Jackson Laboratory.
Chimeric Mice and Lymphoid Organ Cell Transplantation. The generation of these mice has been reported (14) . Briefly, after irradiation, mice received 50 -100 ϫ 10 6 syngeneic splenocytes. Engraftment was confirmed by FACS analysis by using GFP C57BL/6 donor lymphoid organ cells (data not shown).
Intratracheal Instillation (IT).
The tracheas of anesthetized mice were cannulated, and 0.08 mg of bleomycin or sterile 0.9% saline was injected as we have previously described (7, 14) . Bronchoalveolar Lavage (BAL) Analysis. The BAL analysis has been described (6, 7) . A differential count was performed on 200 cells per animal and is expressed as a percentage of total cells recovered.
Lung Collagen Content. Total soluble lung collagen was determined by using the Sircol collagen assay kit (Biocolor) as described previously (43) . Briefly, the upper lobe of the right lung was homogenized in 5 ml of 0.5 mol/liter acetic acid containing 1 mg of pepsin (Sigma-Aldrich) per 10 mg of tissue residue. Samples were incubated at 21°C for 24 h and centrifuged. The optical density of 100 l of supernatant was evaluated at 540 nm with a spectrophotometer. Collagen results are expressed in micrograms.
Isolation of Lung Cells and Myofibroblasts.
The isolation of lung cells and myofibroblasts was previously reported in detail (14) . Briefly, right lungs were incubated at 37°C with collagenase and minced. Typically, 1 week after initiating myofibroblast culture, Ͼ95% of the cells are morphologically myofibroblasts (43) . Coculture Experiments. Lung myofibroblasts and T cells were extracted ex vivo and cocultured for 24 -48 h in RPMI medium 1640 (10% FCS) to determine the induction of cell apoptosis. Myofibroblasts were plated at a density of 2-3 ϫ 10 5 per milliliter in six-well tissue culture plates. Lymphocytes were added when 1 ϫ 10 6 myofibroblasts reached 70 -85% confluence. T cells were harvested from the culture supernatant and analyzed for apoptosis by Annexin V staining and flow cytometry. Contaminating myofibroblasts were excluded by size. The death of myofibroblasts was determined by trypan blue cell staining.
In Vitro Detection of Apoptotic Cells by Annexin V Affinity Labeling. The 1 g of FITC-conjugated Annexin V and 5 g/ml PI (15) were added to 0.5 ϫ 10 6 cells as previously described (14, 44) .
Immunofluorescence Staining of Tissue Sections. As previously reported (14) , sections were incubated with mouse monoclonal anti-␣SMA, rabbit anti-CD3, and/or rat anti-caspase-3 and thereafter with anti-mouse-Cy5 conjugate, anti-rabbit Cy3, and anti-rat-Cy2 Abs, respectively (The Jackson Laboratory) for 30 min at 21°C. CFSE Staining of Myofibroblasts. After culture, 2 ϫ 10 6 myofibroblasts per milliliter were resuspended in PBS and stained with CFSE as previously described (45) . Briefly, an equal volume of 2.5 M CFSE in PBS was added for 8 min at 21°C. Cells were immediately washed three times in RPMI medium 1640 or PBS.
Murine Skin Air Pouch Model for Tracing Transplanted GFP ؉ Lung Myofibroblasts. Mice (6 -8 weeks of age) were anesthetized with 40 l of 85 mg/ml ketamine and 2 mg/ml xylazine, and dorsal air pouches were raised by injecting 3 ml of sterile air s.c. on days 0 and 3 as described previously (20) . The 5 ϫ 10 6 myofibroblasts resuspended in 1 ml of sterile PBS were engrafted into the air pouches of groups of five BALB/c or C57BL/6 mice. Mice were killed 7, 14, and 30 days after myofibroblast injection by a lethal dose (100 mg per mouse in 0.5 ml) of pentothal (CTS). After removal of dorsal skin, a fluorescent binocular microscope (Carl Zeiss) and a Nikon Coolpix digital camera were used to detect green fluorescence in the air pouches. Data quantitation in IOD arbitrary units was performed by using Image ProPlus software (Media Cybermetics).
Pouch Lavage (PL) Analysis. A two-way syringe was injected into the air pouch, and PL was carried out with 3 ml of saline. The total number of cells was counted. A differential count was performed on 200 cells per animal and expressed as the percentage of total cells recovered.
RT-PCR.
Reverse transcription of 1 g of total RNA and random primers in 20-l reactions was performed as previously reported (44) by using the following primers: ␤-actin sense, 5Ј-GTTGCCATCAATGACCCCTTC-3Ј; ␤-actin antisense, 5Ј-CATGT GGGCCATGAGGTCCAC-3Ј; MCP-3 sense, 5Ј-GTCAAGAAACAAAA-GATCCCC-3Ј; and MCP-3 antisense, 5Ј-GGCTTTGGAGTTGGGGTTTTCATGTC-3Ј.
Data Analysis and Statistics. Flow-cytometry experiments were repeated at least two to three times. Data of digital camera fluorescence were analyzed according to fluorescence arbitrary units, presented as mean Ϯ SD, and plotted on graphs. Statistical analysis was performed by using Student's t test for experiments with single comparisons and by using ANOVA with the Bonferroni test for experiments involving multiple comparisons.
